Ratings for Vertex (NASDAQ: VERX) were provided by 7 analysts in the past three months, showcasing a mix of bullish and ...
Scientists from James Cook University have developed a new computer tool that reveals layers of gene activity that were ...
Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback